Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on the day's biggest business stories

Subscribe to Axios Closer for insights into the day’s business news and trends and why they matter

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sign up for Axios NW Arkansas

Stay up-to-date on the most important and interesting stories affecting NW Arkansas, authored by local reporters

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

A health worker administers a dose of the Pfizer-BioNtech COVID-19 coronavirus vaccine to a pregnant woman. Photo: Jack Guez/AFP via Getty Images

The Pfizer and Moderna vaccines are deemed safe and effective for pregnant women, according to a pre-print study out Thursday in the American Journal of Obstetrics & Gynecology.

Why it matters: The study, which has yet to be peer reviewed, is in line with statements from health officials and the World Health Organization that pregnant and lactating women may take the vaccine.

  • Prior to this study, tens of thousands of pregnant women in the U.S. have already been vaccinated without complications.

Details: The study is the largest of its kind due to this group's initial exclusion of the vaccines' clinical trials.

  • 131 women received either of the vaccines: 84 were pregnant, 31 were lactating and 16 weren't pregnant.
  • Antibody levels following vaccination were the same in pregnant and lactating women compared to those who weren't pregnant, the study says.
  • Results also showed that antibodies were passed on to newborns, based on levels measured in breast milk and the placenta.

Go deeper

Linh Ta, author of Des Moines
Mar 25, 2021 - Axios Des Moines

Former Bush official argues that Iowa schools were right to reopen early

Illustration: Brendan Lynch/Axios

Iowa students will be better off academically and health-wise compared to schools that are still partially shut down, argues John Bailey, former deputy policy director at the Commerce Department under George W. Bush.

Why it matters: Schools nationwide will have to grapple with learning losses next fall, but Bailey contends it won't feel as severe for states that opened earlier.

Mar 25, 2021 - World

India pauses vaccine exports amid surge in cases

Waiting for vaccines in New Delhi. Photo: Sonu Mehta/Hindustan Times via Getty

Exports of the Oxford/AstraZeneca vaccine from the world's largest vaccine manufacturer, the Serum Institute of India, have been paused as India grapples with a new spike in cases, Reuters reports.

Why it matters: India hasn't exported any doses at all over the past week, according to foreign ministry data — a worrying sign for the COVAX initiative, which aims to send vaccines all over the world and is relying heavily on Indian-made vaccines.

Mar 25, 2021 - Health

Over 40 states set to expand vaccine eligibility to all adults by May 1

Illustration: Brendan Lynch/Axios

More than 40 states plan to meet President Biden's goal of making all adults eligible for the coronavirus vaccine by May 1, and at least 30 plan to open up eligibility before then, per NYT.

What they're saying: "My thought is that we're going to see a continued decrease in transmission as we open vaccine eligibility," Cindy Prins, an epidemiologist at the University of Florida, told NYT.